This 14-week clinical trial aims to assess the safety and effectiveness of a potential new oral treatment in adults aged 18–65 who experience panic attacks but are not currently taking benzodiazepines or affected by other major psychiatric disorders.
This study is being conducted at our Western Sydney, Central Coast, Canberra, Brisbane and Melbourne sites.
Apply Now
This 3-month study is exploring whether a psilocybin-assisted therapy can help reduce emotional distress and improve well-being in people living with cancer.
This study is only being conducted at our Melbourne site.
Apply Now
This 5-month clinical trial is exploring whether an investigational medicine can help reduce symptoms in people aged 18 to 65 who are living with treatment-resistant depression (TRD).
This study is only being conducted at our Melbourne site.
Apply Now
This study is exploring whether a weekly injection of an investigational medicine, taken with regular antidepressant medication, can help delay the return of major depressive disorder (MDD) symptoms. It is for adults aged 18 to 75 who are currently in remission or near remission but still experience some ongoing symptoms.
This study is only being conducted at our Melbourne site.
Apply Now
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
